Blog
8 Articles
Pancreatic Cancer Research Highlights from ASCO Annual Meeting
The 2025 ASCO meeting featured pancreatic cancer research including a new treatment modality and a new treatment combination.
Phase II/III Clinical Trial Recruiting Advanced Pancreatic Cancer Patients
Dr. Shalini Makawita is a primary investigator in a phase IIb/III immunotherapy clinical trial for advanced pancreatic cancer patients.
Testing a New Chemo and RNA Therapy Combination
Researchers are testing a new drug that binds to messenger RNA in combination with mFOLFIRINOX chemotherapy.
Adapting Chemotherapy Regimens for a Better Pancreatic Cancer Outcome
Researchers are comparing chemotherapy regimens for effectiveness before surgery, and whether switching treatments makes a difference.
Chemo and SBRT for Inoperable Pancreatic Cancer
For inoperable pancreatic cancer, researchers are comparing mFOLFIRINOX and SBRT with gemcitabine-based treatment regimens.
Reeducating Myself About Pancreatic Cancer
Martin Hynes knew all about pancreatic cancer–as a research director he worked on the development of Gemzar. He was able to have a Whipple and is doing well.
Endurance Athlete Enduring Pancreatic Cancer Treatment
After a stage IV pancreatic cancer diagnosis, Dr. Kevin Moore had cytoreductive surgery to remove the metastases in his abdomen.
A New Drug to Target Cancer Cell Enzymes
Researchers are testing a drug that targets the enzymes that help generate energy for cell division, to disrupt pancreatic cancer cell multiplication.